Overall, DN052 was more potent than motolimod in inducing the cytokines including INF-γ, IL-12p40, TNF-α which were reported to be predictive of clinical benefit in motolimod-treated cancer patients [35] suggesting DN052 may have superior efficacy in humans. This evidence concerns the gene TNF and cancer.